NCT06819488View on ClinicalTrials.gov

A Clinical Study of Mass Balance of [14C]HRS-7535

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

April 16, 2025

Study Completion Date

April 16, 2025

Conditions
Type 2 Diabetes MellitusWeight Loss
Interventions
DRUG

[14C]HRS-7535

\[14C\]HRS-7535.

Trial Locations (1)

210029

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06819488 - A Clinical Study of Mass Balance of [14C]HRS-7535 | Biotech Hunter | Biotech Hunter